Status: Recruiting
Evaluation of Safety of Acellular Dermal Matrix(ADM) in Breast Reconstruction
The goal of this observational study is to evaluate the safety of Acellular Dermal Matrix(ADM) processed by CO2 supercritical fluid technology against other acellular dermal matrix products from different companies that have been washed with detergents in patients undergoing breast reconstruction surgery with implants due to the breast cancer.
Participants needed: 120
Trial details
Age: 19-79Biological sex: FemaleType: ObservationalSponsor: DOF Inc.Updated: Apr 28, 2026Locations: 1Duration: 12 Weeks
Eligibility criteria
Female patients aged 19 to 79 years [+4]